Nanomedicine News RSS Feed - Nanomedicine

Nanogel Formulation of Thunder God Vine Compound Holds Promise for Cancer Treatment

Nanogel Formulation of Thunder God Vine Compound Holds Promise for Cancer Treatment

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide. These regrettably poor prognoses are due to the difficulty in treating this cancer using conventional chemotherapeutic drugs such as doxorubicin, epirubicin, cisplatin, 5-fluorouracil, etoposide or combinations therein. [More]
EORTC-NCI-AACR Symposium to Feature BIND Therapeutics’ Presentation on Clinical Activity of BIND-014

EORTC-NCI-AACR Symposium to Feature BIND Therapeutics’ Presentation on Clinical Activity of BIND-014

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that a poster presentation including Phase 2 clinical data on its lead drug candidate, BIND-014, in patients with non-small cell lung cancer (NSCLC) will be presented at the upcoming 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. [More]
Engineered Vault Nanoparticles Could Lead to More Effective Treatments for Cancer and HIV

Engineered Vault Nanoparticles Could Lead to More Effective Treatments for Cancer and HIV

Amultidisciplinary team of scientists from UCLA and Stanford University has used a naturally occurring nanoparticle called a vault to create a novel drug delivery system that could lead to advances in the treatment of cancer and HIV. [More]
Science Translational Medicine Publishes Positive Data on Tekmira's Lipid Nanoparticle Technology for Targeting Marburg Virus

Science Translational Medicine Publishes Positive Data on Tekmira's Lipid Nanoparticle Technology for Targeting Marburg Virus

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced the publication of data in a peer-reviewed scientific journal which highlights positive results in an animal model of Marburg virus infection enabled by Tekmira's lipid nanoparticle (LNP) technology. [More]
Critical Advance in Creating Medical Nanorobots

Critical Advance in Creating Medical Nanorobots

Researchers from the Institute of General Physics of the Russian Academy of Sciences, the Institute of Bioorganic Chemistry of the Russian Academy of Sciences and MIPT have made an important step towards creating medical nanorobots. [More]
Researchers Capture and Release Single-Cells

Researchers Capture and Release Single-Cells

Scientists at the Houston Methodist Research Institute have figured out how to pick up and transfer single cells using a pipette -- a common laboratory tool that's been tweaked slightly. They describe this engineering feat and preliminary test results in a recent issue of the Journal of the American Chemical Society. [More]
NIH Awards $1.15 Million Grant to Train Next Generation of Cancer Nanomedicine Scientists

NIH Awards $1.15 Million Grant to Train Next Generation of Cancer Nanomedicine Scientists

North­eastern Uni­ver­sity has received a five-​​year, $1.15 mil­lion grant from the National Insti­tutes of Health’s National Cancer Insti­tute to train the next gen­er­a­tion of cancer nanomed­i­cine sci­en­tists and clin­i­cians through a unique expe­ri­en­tial learning program. [More]
Nanoparticles in New Chikungunya Virus Candidate Vaccine Mimic Immune-Stimulating Effects of Actual Virus Particles

Nanoparticles in New Chikungunya Virus Candidate Vaccine Mimic Immune-Stimulating Effects of Actual Virus Particles

The first human trial of a new vaccine developed using non-infectious virus-like particles (VLP) appears likely to offer protection against chikungunya virus, a mosquito-borne infection, according to a study published in The Lancet. Since its re-emergence in 2004, chikungunya virus has become a growing public-health threat that has affected millions of people in Africa, Asia, and Europe, and in recent months it has been spreading throughout the Americas. [More]
Vascular Enabled Integrated Nanosecond Pulse Procedure Helps Open Blood-Brain-Barrier

Vascular Enabled Integrated Nanosecond Pulse Procedure Helps Open Blood-Brain-Barrier

A team of researchers from the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences have developed a new way of using electricity to open the blood-brain-barrier (BBB). [More]
Trojan Horse Nanospheres Kill Tumour Cells

Trojan Horse Nanospheres Kill Tumour Cells

A "Trojan horse" treatment for an aggressive form of brain cancer, which involves using tiny nanoparticles of gold to kill tumour cells, has been successfully tested by scientists. [More]